Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

6901.TW

STRONG SELLGet insider-trade alerts

Diamond Biofund Inc. · Financial Services · Taiwan · $490M · Avg Vol: $3M/d

5
StockRank
Q
30
V
25
M
20
P/E (TTM)
ROE
-10.3%
D/E
0.0x
Dividend %

COMPANY DESCRIPTION

Diamond Biofund Inc. is Taiwan's largest venture capital firm specializing in biotechnology and healthcare investments. The firm leverages its deep industry expertise and strategic partnerships to incubate and scale early-stage biotech startups. It acts as a key financial catalyst in Taiwan's life sciences ecosystem, maintaining a dominant market position in local healthcare asset management.

FINANCIAL SUMMARY (USD)

Year20212022202320242025CAGRTTM
Revenue
EPS0.090.03-0.10-0.09-64.8%-0.04
Shares749.3M849.9M851.4M852.8M+13.8%852.9M
Debt0.1M4.1M3.7M2.9M194.7%2.8M
Equity347.0M403.9M325.7M289.6M-5.9%
Op CF14.9M-80.6M35.8M-8.3M55.2%-7.1M
Inv CF77,974-0.8M-97.9M91.1M
Fin CF-5.0M137.0M32,063-0.3M
Loading 1Y...
PRICE (1Y)+42.1%
0.380.440.490.540.60May 25Jun 15Jul 6
SMA 50SMA 200
Close
$0.5935
RSI (14)
67.9
52W High
$0.683
From 52W High
0.9%

SCORE BREAKDOWN

Quality
30
ROIC
-12.6%2.8
ROE
-10.3%5.2
GP/Assets
-9.1%1.1
Op. Margin
109.5%98.8
FCF/Assets
-7.7%7.2
Piotroski
443.6
Int. Cover
-50.0x1.8
D/E Ratio
0.01x94.2
Current Ratio
60.91x96.6
Value
25
P/E (TTM)
N/A
EV/EBITDA
-12.0x25.0
P/FCF
N/A
P/B
1.8x27.8
P/S
-18.1x25.0
Div Yield
N/A
Momentum
20
52W High %
87%36.3
RS 6M
-57%4.6
SMA 50/200
0.91x13.9
EPS Rev 4W
N/A
EPS Rev 12W
N/A
EPS Improve
N/A
Q Growth
N/A

FUNDAMENTALS

Market Cap
$490M
P/E (Forward)
Gross Margin
0.0%

SECTOR PEERS

Closest peers in Financial Services, ranked by industry match, size, and score similarity. Cross-listings of 6901.TW are excluded.

TickerCompanyMkt CapStockRankSignal
6901.TWDiamond Biofund Inc.(you)$490M5STRONG SELL
6958.TWInfinite Finance Co., Ltd.$227M9STRONG SELL
2905.TWMercuries & Associates Holding, Ltd.$490M26SELL
2889.TWIBF Financial Holdings Co., Ltd.$1.7B12STRONG SELL
2836.TWBank of Kaohsiung Co., Ltd.$708M32SELL
6020.TWOTachan Securities Co., Ltd.$177M20SELL
2820.TWChina Bills Finance Corporation$751M34SELL
MMTXMiluna Acquisition Corp$89M9STRONG SELL
2849.TWEnTie Commercial Bank Co., Ltd.$885M35HOLD
6024.TWCapital Futures Corporation$474M50HOLD

Peer medians: ROE 10.5% · P/E 16.0x · Gross margin 35.3%

Diamond Biofund Inc. (6901.TW) — Stock Score Summary

Diamond Biofund Inc. (6901.TW) has a MoatMap StockRank of 5/100 based on Quality (30/100), Value (25/100), and Momentum (20/100) factor scores. The current signal is STRONG SELL.

Diamond Biofund Inc. is Taiwan's largest venture capital firm specializing in biotechnology and healthcare investments. The firm leverages its deep industry expertise and strategic partnerships to incubate and scale early-stage biotech startups. It acts as a key financial catalyst in Taiwan's life sciences ecosystem, maintaining a dominant market position in local healthcare asset management.

Key Financial Metrics

Price$0.59
Market Cap$490M
Price/Book1.76
Return on Equity-10.3%
Return on Invested Capital-12.6%
Debt/Equity0.99
Gross Margin0.0%
Operating Margin109.5%
Free Cash Flow$-23M

Diamond Biofund Inc. operates in the Asset Management industry, part of the Financial Services sector (Taiwan).

Frequently Asked Questions

What is Diamond Biofund Inc.’s (6901.TW) StockRank?
MoatMap’s StockRank for Diamond Biofund Inc. (6901.TW) is 5/100, with a Strong Sell signal. It is a composite of Quality (30), Value (25), and Momentum (20) factor ranks across MoatMap’s 20,000+ stock universe.
Does Diamond Biofund Inc. have an economic moat?
Diamond Biofund Inc. (6901.TW) has a Quality factor score of 30/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Diamond Biofund Inc. a buy, hold, or sell?
MoatMap’s current signal for Diamond Biofund Inc. (6901.TW) is Strong Sell, based on a StockRank of 5/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Diamond Biofund Inc. in?
Diamond Biofund Inc. (6901.TW) operates in the Financial Services sector, specifically the Asset Management industry (Taiwan).